[144] Stem, Inc. SEC Filing
Rhea-AI Filing Summary
This Form 144 is a Rule 144 notice reporting a proposed sale of common stock by a person who acquired the shares through restricted stock vesting. The filer plans to sell 5,951 shares of common stock through Fidelity Brokerage Services LLC with an aggregate market value of $81,203.78. The filing lists 8,359,047 shares outstanding. The securities were acquired on 08/07/2025 by Restricted Stock Vesting from the issuer and the stated nature of payment is compensation. The approximate date of sale is 08/11/2025. The notice also reports Nothing to Report for securities sold in the past three months and includes the standard signer representation about material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine Rule 144 disclosure of vested shares; transaction is documented and uses a broker for planned sale.
The filing documents a proposed sale of 5,951 common shares via Fidelity Brokerage Services LLC with an aggregate market value of $81,203.78. The securities were acquired by Restricted Stock Vesting on 08/07/2025 and the sale is scheduled for 08/11/2025. The form reports no sales in the prior three months. From a compliance perspective, the notice fulfills Rule 144 disclosure requirements by specifying acquisition details, broker, amount, and planned sale timing.
TL;DR: Disclosure indicates insider disposal of compensation shares under Rule 144; document provides required transaction details.
The filer identifies the acquisition as Restricted Stock Vesting with payment characterized as compensation, and lists the broker and exact share count. The filing includes the customary signer representation that no undisclosed material adverse information exists. There are no reported sales in the past three months. This filing is a routine governance disclosure documenting a planned sale of vested compensation shares.